April 17, 2025

Eyebrows Signal Understanding Gaps in Conversation

Eyebrow furrows can silently signal 'I've not received enough information.'

Conexiant

April 17, 2025

We Want Your Perspective!

Join our roster of respected specialists and share your clinical perspectives.

Conexiant

April 16, 2025

E-Cigs + Cigarettes: Worse Disease Odds

"There is a need to reassess the assumption that e-cigarette use provides substantial harm reduction across all cigarette-caused diseases, particularly accounting for dual use," warns a comprehensive meta-analysis.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Tenecteplase Matches Alteplase in Stroke Outcomes

In a registry-based study of 79,550 patients, tenecteplase showed comparable short-term safety and effectiveness to alteplase for acute ischemic stroke, with no significant differences in functional outcomes or hemorrhagic events.

Conexiant

April 10, 2025

Microplastics Linked to Brain Disability Spike

Higher rates of cognitive, mobility, and self-care disabilities found in coastal counties with elevated marine microplastic levels.

Conexiant

April 10, 2025

Morning Coffee Consumption Linked to Lower Mortality Risk

“Drinking coffee in the morning may be more strongly associated with a lower risk of mortality than drinking coffee later in the day."

Conexiant

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant